Topical virucidal composition for treatment of mucocutaneous tissue
OwnerStanley Marcus, Wendy Y. Kiminventors
Life of this patent
Estimating the term…
Abstract
This invention pertains to a topically applied composition with a virucidal impact on mucocutaneous tissue. Ingredients essential to the efficacy of the formulated combination include a polyethylene glycol polymer known as Nonoxynol-9("N-9")in admixture with selected fat soluble vitamins A, D and E in the form of vegetable oil (and) retynyl palmitate (and) ergocalciferol together with tocopherol acetate. The invention is directed particularly to inactivation of herpes virus and human papilloma virus as manifested in cold sores, lesions, fever blisters, canker sores and warts. The N-9 contains viral activity while the vitamins effect restoration and strengthening of the damaged tissue cells.
Claims8
A non-cosmetic virucidal composition for medicinally therapeutic and prophylactic topical treatment of mucocutaneous oral tissues the active ingredients of which, in combination, consist of:
- a polyethylene glycol polymer with a molecular weight of 968 present in concentrations between two and five percent by weight;
- and
- a combination of fat soluble vitamins present in an amount between 0.2 and one percent by weight.
A non-cosmetic virucidal composition for medicinally therapeutic and prophylactic topical treatment of mucocutaneous oral tissue comprising, in combination, a mixture of polyethylene glycol polymer with a molecular weight of 968 present in concentrations of between two and five percent by weight, and a combination of fat soluble vitamins present in concentrations of between 0.2 and one percent respectively, wherein:
- the polyethylene glycol polymer has a molecular structure which equates to that of nonoxynol-9;
- and
- the combination of fat soluble vitamins consists of vegetable oil and retinyl palmitate and ergocalciferol and tocopherol acetate.
Dependencies are inferred from the claim text.